Skip to content

Vanson-Halosource, Inc.

Country not established

Devices
1

What Vanson-Halosource, Inc. makes

Vanson-Halosource, Inc. manufactures the Hemohalt Hemostasis Pad, a device designed for controlling bleeding by applying pressure and promoting clotting at wound sites.

The Hemohalt Hemostasis Pad is classified as a Class II device under FDA regulations and is listed in the 510(k) clearance registry. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Hemohalt Hemostasis Pad Ref K060409

    Active Regimes: 510(k) Registry: 510(k) Class:—

Frequently asked questions

How many devices does Vanson-Halosource, Inc. have in the registry?

The registry currently lists 1 device for Vanson-Halosource, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Vanson-Halosource, Inc.'s devices?

Among its 1 most recently registered device, Vanson-Halosource, Inc. has devices listed in FDA 510(k) (1 device).

What are the newest devices from Vanson-Halosource, Inc. in the registry?

The most recently registered devices listed for Vanson-Halosource, Inc. include HEMOHALT HEMOSTASIS PAD.

Generated automatically from registry data and not verified by a human reviewer.